European Respiratory Society Monograph, Vol. 49. 2010
ISBN: 978-1-849840-05-7
DOI: 10.1183/1025448x.erm4910
Research within in the field of airway and lung inflammation has expanded tremendously during recent decades. Attempts are continuously being made to find novel methods to mirror and monitor inflammatory reactions related to airway disorders and dysfunction. The lungs are particularly well suited for this purpose as we have easy access to exhaled air and thereby a possibility to develop methods that measure compounds directly released from them.
As this area of interest is rather new this is the first issue of the
European Respiratory Monograph to focus on inflammatory markers. As this field is rapidly expanding it was decided, after some initial discussions, to limit this Monograph to markers in exhaled air and to produce a comprehensive update of the entire field.
The Guest Editors
Eur Respir Monogr 2010; 49: v |  |
Preface K. Larsson Eur Respir Monogr 2010; 49: vi |  |
Introduction I. Horvath, J. de Jongste Eur Respir Monogr 2010; 49: vii |  |
Basic aspects of exhaled nitric oxide K. Alving, A. Malinovschi Eur Respir Monogr 2010; 49: 1-31 |   |
Exhaled nitric oxide in asthma D.E. Shaw, E. Wilson, I.D. Pavord Eur Respir Monogr 2010; 49: 32-44 |   |
Exhaled nitric oxide in respiratory diseases other than asthma M.W.H. Pijnenburg Eur Respir Monogr 2010; 49: 45-55 |   |
Exhaled nitric oxide in infants: a marker of inflammation? F. Singer, P. Latzin Eur Respir Monogr 2010; 49: 56-70 |   |
Nasal nitric oxide M. Maniscalco, J.O. Lundberg Eur Respir Monogr 2010; 49: 71-81 |   |
Exhaled carbon monoxide: mechanisms and clinical applications T. Dolinay, A.M.K. Choi, S.W. Ryter Eur Respir Monogr 2010; 49: 82-95 |   |
Methodological issues of sample collection and analysis of exhaled breath A. Amann, W. Miekisch, J. Pleil, T. Risby, J. Schubert Eur Respir Monogr 2010; 49: 96-114 |   |
Interpretation of exhaled volatile organic compounds G. Pennazza, M. Santonico, E. Martinelli, A. D'Amico, C. Di Natale Eur Respir Monogr 2010; 49: 115-129 |   |
Exhaled volatile organic compounds as biomarkers for respiratory diseases P.J. Mazzone Eur Respir Monogr 2010; 49: 130-139 |   |
Exhaled volatile organic compounds in nonrespiratory diseases M. Corradi, P. Gergelova, A. Mutti Eur Respir Monogr 2010; 49: 140-151 |   |
Exhaled breath condensate sample collection: standards and open issues E. Dompeling, P.P.R. Rosias, Q. Jöbsis Eur Respir Monogr 2010; 49: 152-161 |   |
Exhaled breath condensate: hydrogen peroxide S. Loukides, P. Bakakos, K. Kostikas Eur Respir Monogr 2010; 49: 162-172 |   |
Exhaled breath condensate pH A. Bikov, B. Antus, G. Losonczy, I. Horvath Eur Respir Monogr 2010; 49: 173-182 |   |
Exhaled breath condensate: adenosine, ATP and other purines Z. Lázár, G. Vass, É. Huszár, G. Losonczy, I. Horváth Eur Respir Monogr 2010; 49: 183-195 |   |
Exhaled breath condensate: 8-isoprostane and eicosanoids P. Montuschi Eur Respir Monogr 2010; 49: 196-206 |   |
Exhaled breath condensate: nitric oxide-related compounds L.E. Donnelly Eur Respir Monogr 2010; 49: 207-216 |   |
Interleukins and other proteins C. Gessner, H. Wirtz Eur Respir Monogr 2010; 49: 217-230 |   |
Exhaled breath condensate: metabolomics S. Carraro, G. Giordano, M. Stocchero, E. Baraldi Eur Respir Monogr 2010; 49: 231-236 |   |
Future perspectives on exhaled biomarkers P.J. Barnes Eur Respir Monogr 2010; 49: 237-246 |   |
Summary and future developments J.C. de Jongste, I. Horvath Eur Respir Monogr 2010; 49: 247-249 |  |